Chugai Pharm Unsp/Adr (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 09-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,103,738 | 3,429,907 | 2,794,565 | 2,706,519 | 3,101,182 |
| Marketable Securities | 2,896,902 | 3,660,595 | 3,439,465 | 2,957,112 | 2,021,410 |
| Receivables | 2,406,207 | 2,187,003 | 1,946,888 | 2,196,622 | 1,614,171 |
| Inventories | 1,675,017 | 1,625,129 | 1,538,394 | 1,830,420 | 1,853,769 |
| Other current assets | 238,696 | 272,136 | 288,938 | 232,429 | 265,904 |
| TOTAL | $10,320,560 | $11,174,770 | $10,008,250 | $9,923,102 | $8,856,436 |
| Non-Current Assets | |||||
| PPE Net | 3,057,348 | 3,151,610 | 2,960,087 | 2,855,996 | 2,789,458 |
| Intangibles | 232,315 | 229,715 | 114,312 | 139,521 | 131,045 |
| Other Non-Current Assets | 1,238,171 | 1,164,499 | 1,037,936 | 948,619 | 938,081 |
| TOTAL | $4,527,834 | $4,545,824 | $4,112,335 | $3,944,136 | $3,858,584 |
| Total Assets | $14,848,400 | $15,720,590 | $14,120,580 | $13,867,230 | $12,715,020 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 536,500 | 541,077 | 465,868 | 511,170 | 594,424 |
| Other current liabilities | 987,095 | 814,628 | 645,460 | 720,230 | 811,839 |
| TOTAL | $1,818,476 | $1,851,104 | $1,375,631 | $1,684,688 | $1,601,173 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 116,477 | 106,991 | 101,026 | 55,047 | 65,640 |
| TOTAL | $177,194 | $172,107 | $157,291 | $113,377 | $112,138 |
| Total Liabilities | $1,995,671 | $2,023,211 | $1,532,923 | $1,798,066 | $1,713,311 |
| Shareholders' Equity | |||||
| Common Shares | 497,774 | 505,094 | 483,133 | 490,453 | 490,453 |
| Retained earnings | 11,920,520 | 12,747,870 | 11,552,390 | 11,063,420 | 10,032,090 |
| Other shareholders' equity | -44,209 | -40,454 | 89,210 | 47,741 | 13,383 |
| TOTAL | $12,852,730 | $13,697,380 | $12,587,670 | $12,069,160 | $11,001,710 |
| Total Liabilities And Equity | $14,848,401 | $15,720,591 | $14,120,593 | $13,867,226 | $12,715,021 |